Cocrystal pharma expects to grant underwriters option to purchase up to additional 15% common shares

Cocrystal pharma, inc. announces proposed underwritten public offering of common stock.cocrystal pharma - expects to grant underwriters 45-day option to purchase up to additional 15% of shares of common stock offered in public offering.
COCP Ratings Summary
COCP Quant Ranking